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Cytochrome P450 2B1 mediates oxidant injury in puromycin- PAN is not well understood. Reactive oxygen metabo-
induced nephrotic syndrome. lites (ROM) and catalytic iron have been implicated as
Background. Reactive oxygen metabolites (ROM) are im- potential mediators of this glomerular injury [2]. Thereportant mediators of puromycin aminonucleoside (PAN) in-
is virtually no information as to the intracellular site forduced minimal change nephrotic syndrome (NS) in rats. We
the generation of ROM in this model of NS.have recently shown that cytochrome P450 (CYP) is a signifi-
cant source of catalytic iron in this model of glomerular injury. Cytochrome P450 (CYP) is a group of hemeprotein
The current study was designed to identify the CYP isozyme(s) that acts primarily as monooxygenases in the synthesis
in the rat glomeruli and explore the role of the specific iso- and metabolism of many endogenous and exogenouszyme(s) in PAN-induced minimal change NS.
compounds [3]. During the nicotinamide adenine dinu-Methods. NS was induced in rats by a single intravenous in-
cleotide phosphate (NADPH)-dependent electron trans-jection of PAN. Animals were sacrificed at different time points
for variety of biochemical assays including Western blot, immu- fer CYP can function as oxidases and generate superox-
nohistochemistry and reverse transcription-polymerase chain re- ide anion and hydrogen peroxide (H2O2) [4, 5]. Theseaction (RT-PCR). Ultrastructural histochemistry was utilized to
initial ROM may serve as precursors for the generationstudy hydrogen peroxide (H2O2) generation in the kidney.
of other potent oxidants. Gutteridge has demonstratedResults. Several CYP isozymes were tested and CYP2B1
was localized exclusively in the rat glomeruli but not in the that the H2O2 and organic hydroperoxides can oxida-
tubules. Treatment with PAN resulted in the generation of tively degrade hemoglobin and promote the release of
H2O2 in the glomerular basement membrane with significant iron from the heme chelate [6]. The heme moiety of
loss of CYP2B1 content accompanied by a marked increase
CYP therefore may serve as an intracellular source of ironin the catalytic iron. CYP2B1 inhibitors cimetidine and piperine
capable of catalyzing free radical reactions. Recent stud-significantly reduced H2O2 generation, and prevented the loss
of CYP2B1 content and the increase in the catalytic iron. ies, including ours, indicate that the iron rich enzyme,
CYP2B1 inhibitors also provided significant protection against CYP, may serve as an important source of catalytic iron
PAN induced proteinuria. The induction of heme oxygenase in models of tissue injury including PAN induced NS
and ferritin also was observed in the glomeruli in PAN-treated
[7–11].rats. Both cimetidine and piperine reduced the up-regulation
We postulate that PAN causes glomerular damage byof these proteins.
Conclusion. Our data indicate that CYP2B1 plays an impor- interacting with CYP in the glomerular cells resulting in
tant role in PAN induced NS by serving as a site for ROM the generation of H2O2. The CYP then would be inacti-
generation and a significant source of catalytic iron. vated and catabolized with the release of catalytic iron
and heme. The release of iron would promote the gener-
ation of hydroxyl radical causing injury, and stimulate
Puromycin aminonucleoside (PAN)-induced nephrotic the synthesis of ferritin, which is an iron scavenger. The
syndrome (NS) is a model of minimal change disease in release of heme would cause the induction of heme oxy-
humans [1]. The pathogenesis of the glomerular damage genase (HO-1), which is considered to be protective
and the proteinuria that follows the administration of (Fig. 1) [12].
Based on our hypothesis the current study was de-
signed to (1) identify and localize the specific CYP iso-
Key words: reactive oxygen metabolites, puromycin aminonucleoside,
zymes present in the glomeruli; (2) examine the effectheme oxygenase-1, minimal change nephrotic syndrome, catalytic iron,
glomerular injury. of the inhibitors of the CYP isozyme(s) on PAN induced
proteinuria; (3) determine the role of the CYP iso-Received for publication January 9, 2002
zyme(s) as a site for the generation of ROM; (4) exploreand in revised form March 11, 2002
Accepted for publication April 10, 2002 the role of the CYP isozyme(s) in the induction of HO-1
and ferritin. 2002 by the International Society of Nephrology
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Isolation of glomeruli
Glomeruli were isolated by a combination of sieving
and differential centrifugation as in our previous studies
[13, 19]. Glomeruli isolated from two rats were pooled
together (as N of 1) for the isolation of microsomes.
Preparation of microsome fraction
Glomeruli isolated from rat kidneys were suspended
in an extraction buffer containing 20 mmol/L Tris-HCl,
pH 7.4, 0.25 mol/L sucrose, 1 mmol/L ethylenediamine-
tetraacetic acid (EDTA) and protease inhibitor cocktail
Fig. 1. Hypothesis. (25 mg protein/1 L of cocktail; Sigma) and frozen at
80C. Subsequently, the glomeruli were thawed and
sonicated [20]. The homogenate was centrifuged at
15,000  g, for 20 minutes at 4C. The supernatant ob-METHODS
tained was again centrifuged at 105,000  g for 60 min-
PAN-induced nephrotic syndrome utes at 4C. The sedimented microsomal pellet was resus-
Male Sprague-Dawley rats weighing 200 to 250 g were pended in above extraction buffer to give a protein
injected with saline or a single intravenous injection of concentration of approximately 10 mg/mL [21].
PAN (Sigma, St. Louis, MO, USA) in a dose of 7.5 mg/
100 g body weight (BW; day 0) as in our previous study Bleomycin-detectable iron assay
[13]. Animals were housed in separate metabolic cages Iron capable of catalyzing free radical reactions was
and allowed free access to rat chow (Ralston Purina, St. measured by bleomycin-detectable iron assay as de-
Louis, MO, USA). Daily urine protein excretion was scribed by Gutteridge et al [22, 23] and as detailed in
determined and animals were sacrificed on day 7. Blood our previous studies [7, 8, 13, 24].
was obtained for the measurement of serum albumin
and the evaluation of renal function as measured by Cytochrome P-450 2B1 activity
blood urea nitrogen (BUN) and plasma creatinine. Cell
CYP2B1 activity was assayed by measuring resorufinfraction of the glomeruli was prepared for bleomycin-
formation from 7-pentoxyresorufin according to the pro-detectable iron assay, and the microsome fraction was
cedure of Burke et al [25]. The reaction mixture con-utilized for the measurement of CYP2B1 content and
taining the microsomal protein, 5 mol/L 7-pentoxyre-activity.
sorufin and 0.1 mol/L phosphate buffer were equilibrated
for one minute at 37C. The reaction was started by theInhibition of cytochrome P-450 2B1
addition of 10 L of 50 mmol/L NADPH. The accumula-Two different inhibitors of CYP were used. Piperine
tion of resorufin was measured by setting the fluorimeter(PIP), a methylenedioxyphenyl compound in black and
excitation and emission wavelengths at 550 and 582 nm.red pepper, inhibits CYP2B1 by forming an inhibitory
The formation of resorufin was calculated by comparingcomplex with CYP [14, 15]. Our pilot study showed inhi-
the rate of increase in fluorescence of test samples tobition of CYP2B1 activity in the glomerular microsome
the fluorescence of known amounts of resorufin.fraction in PIP treated rats. To determine the effect of
the CYP2B1 inhibitor in PAN-induced NS, PIP (85
Western blot analysismg/kg BW) was administered by an intraperitoneal injec-
The microsome fraction obtained was subjected totion 16 hours prior to PAN injection and then once a
sodium dodecyl sulfate-polyacrylamide gel electropho-day (based on the pilot studies, data not shown). Another
resis (SDS-PAGE) in 1 mm-slab gels. The separatedgeneral CYP inhibitor, cimetidine (CM), which has been
forms were transferred from the gel to a nitrocelluloseshown to inhibit CYP2B1, also was used [16]. It has an
sheet using a Mini Trans-Blot electroblotting unit (Bio-imidazole and cyano group that inhibits CYP by inter-
Rad, Hercules, CA, USA). The primary antibodies wereacting with the heme moiety [17]. This effect of CM is
monoclonal anti-HO-1 (OSA-111; StressGen, Victoria,specific for CYP, as it does not interact with other heme
BC, Canada) and monoclonal anti-CYP2B1 (PM25; Ox-enzymes [18]. CM was administered by intraperitoneal
ford Biomedical Research, Oxford, MI, USA). Subse-injection (120 mg/kg BW) one hour prior to PAN injec-
quent to primary and secondary antibody (peroxidase-tion and then twice a day as in our previous study [11]. All
labeled) treatment, the blots were visualized by enhancedexperimental procedures were conducted in accordance
with our Institutional Guidelines. chemiluminescence (ECL) method [26].
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Immunohistochemistry amplification conditions for PCR were a hot start of 94C
for five minutes, followed by cycling of one minute atKidney cortical sections were fixed in 10% buffered
60C, one minute at 72C and one minute at 94C for 30formalin for six hours and embedded in paraffin. After
cycles. The reaction was finished within two minutes atdeparaffinization and antigen retrieval, the sections were
60C and 10 minutes at 72C. The PCR products wereimmunolabeled and visualized according to an avidin-
visualized on a 2% agarose gel using ethidium bromidebiotin complex (ABC) method [27]. The primary anti-
and ultraviolet transillumination.body for detection of ferritin was polyclonal anti-Ferritin
(L subunit) antibody (605022; Boehringer Mannheim
Other assaysCorp., Indianapolis, IN, USA).
Blood urea nitrogen (BUN) and creatinine were mea-
Ultrastructural localization of H2O2 sured by using Sigma assay kits.
The principle of this method is that cerium ions com-
Statistical analysisbine with H2O2 generated by the cell that results in a
Values are expressed as mean  standard error (SE).precipitate with properties suitable for ultrastructural
Statistical analysis was performed using unpaired t testhistochemistry [28]. Localization of H2O2 generation was
(for only two groups) and analysis of variance (ANOVA;performed following the procedure of Neale et al [29].
for more than two groups). Statistical significance wasFollowing PAN treatment, the left kidney was perfused
considered at P  0.05.at 37C by retrograde aortic perfusion with 4 mL of each
of the following solutions: (a) PBS; (b) 20 mmol/L Tris-
maleate buffer (pH 7.2) containing 7% sucrose (TMS);
RESULTS(c) TMS containing 1 mmol/L aminotriazole; (d) TMS
Cytochrome P450 isozymes such as CYP3A, 4A, 2E1containing 10 mmol/L aminotriazole, 1 mmol/L cerium
and 2B1 were specifically tested. CYP2B1 was identifiedchloride heptahydrate and 2.56 mmol/L -NADPH; and
and localized to the glomeruli but not the tubules by(e) TMS followed by 10 mmol/L of 2.5% glutaraldehyde
immunohistochemistry, Western blot and CYP2B1 activ-as the fixative. Pieces of the kidney were fixed further
ity (Fig. 2). Intravenous administration of PAN resultedfor two hours in glutaraldehyde and embedded in Epon.
in significant proteinuria on the fourth day and nephroticSections from the tissue block were routinely stained
range proteinuria by day 7 (Fig. 3A). Treatment withwith 4% aqueous uranyl acetate and alkaline lead, and
the CYP2B1 inhibitors PIP and CM provided significantexamined under a Leo 906 electron microscope.
protection against PAN induced proteinuria on day 4 and
Reverse transcription-polymerase chain throughout the course of the study (Fig. 3A). Injection of
reaction (RT-PCR) PAN also resulted in a significant decrease in the serum
albumin level and this decrease was prevented by theRNA was isolated from the kidney cortex using TRIzol
administration of the CYP inhibitors (Fig. 3B). PANReagent (Gibco BRL, Gaithersburg, MD, USA). Reverse
treated animals had developed ascites and significanttranscription of 0.5g of total RNA was carried out using
weight gain at the time of sacrifice compared to theMoloney murine leukemia virus reverse transcriptase
control animals and those treated with CYP inhibitors(Gibco BRL). The resulting first-strand cDNA prepara-
PIP and CM. Renal function as measured by serum creat-tions were used as templates for polymerase chain reaction
inine was similar in all the groups (control, 0.72  0.2;(PCR). HO-1 primers described by Paschen et al [30]
PAN, 0.85  0.2; PIP, 1.10  0.6; CM, 0.69  0.1were purchased from Gibco BRL. The sense primer was:
mg/dL), while the BUN was slightly but significantly5	-TGGAAGAGGAGATAGAGCGA-3	, and the anti-
elevated in rats treated with PAN and CYP inhibitorssense 5	-TGATGAGCAGGAAGGCGGTC-3	. The am-
compared to control animals (control, 21 3; PAN, 33plification product length was 451 bp. GAPDH sense was:
4a; PIP, 38  3a; CM, 28  3a mg/dL; aP  0.05 vs.5	-TCCCTCAAGATTGTCAGCAA-3	; and GAPDH
antisense: 5	-AGATCCACAA CGGATACATT-3	. The control).

Fig. 6. Immunohistochemistry studies of rat renal cortex. The first column shows representative photographs using primary antibodies to CYP2B1
in animals injected with saline, versus animals injected with PAN at 6 hours post-injection, at 4 days post-injection, and in animals that have been
treated with piperine or cimetidine at 6 hours after PAN injection. The second column shows the same animals studied with primary antibodies
to heme oxygenase. The third column shows the same animals studied with primary antibodies to ferritin. Note that CYP2B1 is expressed in the
saline injected rat and in the rat with piperine or cimetidine treatment, but is absent in the glomerulus 6 hours after PAN injection, and decreased
at 4 days after injection. Both heme oxygenase and ferritin are virtually absent in the saline injected animal, but highly expressed in glomeruli
and tubular epithelium following PAN injection at 6 hours and 4 days, with decreased levels of expression in the animals treated with piperine
and cimetidine.
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Fig. 2. Identification and localization of
CYP2B1 in the rat kidney. (A) Immunohisto-
chemistry, (B) Western blot and (C ) specific
CYP2B1 activity indicate that CYP2B1 is
present in the glomeruli but not in the tubules.
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Fig. 3. (A) Effect of cytochrome P450 (CYP) in-
hibitors on the proteinuria (mg/24 h urine) in rats
treated with puromycin aminonucleoside (PAN).
Symbols are: () control, N 
 6; (•) PAN, N 
 10;
() CM, N 
 6; () PIP, N 
 8. (B) Effect of
CYP inhibitors on the serum albumin (g/dL) in rats
treated with PAN. Values are means  SE, N 
 6
to 10. *P  0.05 compared with the rats treated
with PAN alone. P  0.05 compared with the
control rats.
Fig. 4. Localization of H2O2 by a histo-
chemical cerium-H2O2 precipitation method
in rat kidney 6 hours after PAN injection.
(A) Control animals did not show any reac-
tion product. (B) PAN treated rats demon-
strated electron dense granular cerium-pre-
cipitation reaction product in the glomerular
capillary basement membrane. (C ) The ce-
rium-H2O2 precipitation in the glomerular
basement membrane was significantly re-
duced in the rats treated with the CYP2B1
inhibitor PIP. (D) Rat glomeruli showed
marked fusion of podocyte foot processes
4 days after PAN injection (E). Treatment
with PIP prevented the PAN-induced fu-
sion of the foot processes (magnification
15,000).
We postulated that the generation of H2O2 from the content in the glomeruli in PAN treated rats. The bleo-
mycin-detectable iron content in the glomeruli in theinteraction of CYP with PAN results in inactivation of
the CYP with the release of iron and heme. Using an in PAN treated animals was markedly elevated compared
to the control animals (Fig. 5). Both CYP inhibitorsvivo ultrastructural cerium histochemistry technique for
H2O2 localization [29], we demonstrated the presence of PIP and CM significantly prevented the increase in the
bleomycin detectable iron content in the glomeruli inelectron-dense granular precipitate (H2O2-cerium com-
plex) diffusely distributed throughout the glomerular the rats subjected to PAN injection (Fig. 5).
If CYP2B1 is a site for ROM generation and a majorbasement membrane at one hour (data not shown) and
more extensively at six hours following PAN injection source of catalytic iron then it could be anticipated that
there would be a marked reduction in the CYP2B1 con-(Fig. 4B). The cerium-H2O2 reaction product in the glo-
merular basement membrane was significantly attenu- tent in the glomeruli in PAN treated animals. The CYP
inhibitors that markedly decreased the H2O2 generationated in the PAN rats treated with the CYP2B1 inhibitor
PIP (Fig. 4C). Control animals did not show any reaction and prevented the increase in the bleomycin detectable
iron should prevent the loss of CYP2B1 content in theproduct in their basement membrane (Fig. 4A). On the
fourth day with the onset of proteinuria there was the glomeruli. Indeed, the CYP2B1 content in the glomeruli
in the PAN treated rats was markedly decreased as mea-marked fusion of the foot processes noted in the PAN
treated animals (Fig. 4D). Of interest was that treatment sured by immunohistochemistry and Western blot (Figs.
6 and 7). On the other hand, CYP inhibitors PIP and CMwith PIP resulted in significant preservation of the foot
processes (Fig. 4E). We next examined the effect of CYP prevented the loss of CYP2B1 content in the glomeruli of
the rats injected with PAN (Figs. 6 and 7).inhibitors PIP and CM on the bleomycin-detectable iron
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Fig. 5. Effect of CYP inhibitors on the bleomycin
detectable iron content in the glomeruli of PAN
treated rats. Values are means  SE, N 
 3 to 5,
*P  0.05 compared with control rats, P  0.05
compared with the rats treated with PAN alone.
Fig. 7. Western blot analysis of CYP2B1 protein in the glomeruli of rats
injected with PAN with or without administration of CYP inhibitors CM
and PIP. The blots are representative of results from six to ten animals
per experimental group at 6 hours and 7 days after PAN injection.
Fig. 9. Induction of HO-1 mRNA in the kidney of PAN treated rats
and the effect of CYP2B1 inhibitor piperine (PIP) on this induction.
(A) Agarose gel (2%) electrophoresis of RT-PCR products of HO-1
mRNA and GAPDH mRNA (amplified at the same time for the internal
standard). (B) OD values for HO-1 mRNA at each time point are
expressed compared with the values for GAPDH. HO-1 mRNA expres-
sion in the kidney was significantly increased at one hour after PAN
injection and continued to increase until day 4. Administration of
CYP2B1 inhibitor piperine markedly reduced the induction of HO-1
mRNA at each time point. The OD values are means  SE, N 
 3,
P  0.05 compared with control level.
Fig. 8. Western blot analysis of HO-1 protein in the glomeruli of rats
injected with PAN with or without administration of CYP inhibitors
CM and PIP. Blots are representative of results from six to ten animals was a marked decrease in the CYP2B1 content in theper experimental group at 6 hours and 7 days after PAN injection.
glomeruli and significant increase in the content of ferri-
tin both in the glomeruli and the tubules compared to
the control animals as demonstrated by immunohisto-
Oxidant stress induces HO-1, the rate-limiting enzyme chemistry (Fig. 6). CYP inhibitors PIP and CM, which
in heme degradation, which has been shown to be protec- preserved the CYP2B1 content in the glomeruli, mark-
tive in several nephrotoxic models of renal injury [31, 32]. edly reduced the up-regulation of ferritin (Fig. 6).
Administration of PAN resulted in marked induction of
HO-1 in the glomeruli and tubules at 6 hours and day 4
DISCUSSIONby immunohistochemistry (Fig. 6), Western blot (Fig. 8),
and RT-PCR (Fig. 9). CYP inhibitors PIP and CM sig- Cytochrome P450 2B1 was identified and localized, to
our knowledge for the first time, in the rat glomeruli butnificantly attenuated the induction of HO-1 in the glo-
meruli and tubules (Figs. 6, 8, and 9). not in the tubules by CYP2B1 activity, Western blot and
immunohistochemistry. There is only scant informationThe degradation of CYP hemeprotein results in the
release of iron, which stimulates ferritin synthesis. Ferri- with regards to the presence of CYP isoforms in the
glomeruli. Endou et al observed that CYP is localizedtin provides a storage site for iron and sequesters circulat-
ing free iron, thus preventing it from participating in only in the proximal tubules but not in the glomeruli
[34]. Ogita et al have isolated two distinct forms of CYPsubsequent oxidant injury [33]. In PAN treated rats there
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(P450a and b) from kidney cortex of rabbits treated with was markedly elevated in the PAN treated animals asso-
ciated with a significant reduction in the CYP2B1 contentphenobarbital. P450a catalyzed the -hydroxylation of
prostaglandin A1 (PGA1) whereas P450b preferentially in the glomeruli.
The CYP inhibitors that markedly decreased the H2O2metabolized drugs and chemicals [35]. Recent work by
Ito and co-workers has shown CYP4A to be present in generation prevented the increase in the bleomycin de-
tectable iron and the loss of CYP2B1 content in thethe rat glomeruli [36]. In our study the CYP2B1 was
specifically tested besides several other isozymes because glomeruli, and there also was preservation of the individ-
ual foot processes of the epithelial cells with significantof its unique capability to generate free radicals and
the near complete conversion of the degraded heme to protection against PAN induced proteinuria. Thus, taken
together our data strongly suggest that CYP2B1 playsbiliverdin by HO-1 [37, 38].
The importance of CYP in the pathological process an important role in PAN induced NS by serving as a
major site for the generation of ROM and a significantof the kidney during the past few years seems to be
increasing [39, 40]. However, its role as a source of ROM source of iron capable of catalyzing free radical reactions.
Bissell and Hammaker based on their study with bacte-in the kidney has not been fully explored. CYP, a family
of heme mono-oxygenases, catalyze the oxidation of a rial endotoxin indicated that agents promoting the induc-
tion of HO-1 cause a release of heme from CYP, whichwide range of endogenous and exogenous compounds
[3]. Superoxide anion, H2O2 and hydroxyl radical can be in turn causes the stimulation of HO-1 [45]. Nath et al
provided the initial evidence that induction of HO-1formed in the CYP catalyzed reactions [41, 42]. These
ROM are of physiologic and pathologic importance due can be protective in nephrotoxic models of renal injury
[31, 32]. Recent in vivo and in vitro studies provide fur-to their damaging effect leading to the alteration of cellu-
lar macromolecules such as DNA, proteins and lipids. ther genetic evidence that the up-regulation of HO-1
serves as an important adaptive mechanism in the protec-There is evidence that ROM plays a major role in
glomerular damage and the development of proteinuria tion of cells against oxidative injury [46–48]. Our current
study shows a significant induction of HO-1 and synthesisin the PAN induced NS [2]. The precise site and the
source responsible for the generation of ROM are cur- of ferritin both in the glomeruli and tubules following
marked generation of H2O2. The CYP inhibitors thatrently not known. In the present study we examined the
in situ generation and location of ROM in the glomeruli markedly attenuated the H2O2 generation also prevented
the destruction of CYP2B1 and reduced the up-regula-of rats injected with PAN. Using an ultrastructural ce-
rium histochemistry technique we demonstrated granu- tion of HO-1 and ferritin. The induction of HO-1 and
ferritin in the renal tubules is possibly a secondary re-lar electron dense precipitate throughout the glomerular
basement membrane as early as one and six hours follow- sponse to glomerular inflammation. Tumor necrosis fac-
tor-alpha (TNF-), interleukin-1 and other cytokines areing PAN injection. There was little or no cerium-H2O2
reaction product in the PAN animals treated with recognized as inducers of HO-1 [49, 50]. The up-regula-
tion of TNF- in the glomeruli has been demonstratedCYP2B1 inhibitor PIP. These results provide direct evi-
dence that the interaction between CYP2B1 and PAN in PAN induced nephrosis [51, 52]. It is likely that the
pro-inflammatory cytokines, such as TNF- produced inleads to the generation of H2O2 in the glomeruli espe-
cially the glomerular basement membrane. The precise the glomeruli and taken up by the tubules from the
urinary space or by peritubular uptake, may serve aslocation of the production of H2O2 is not demonstrable
by this technique because H2O2 is well known to diffuse inducers of HO-1 in the renal tubules. Another possible
explanation relates to the leakage of transferrin into therapidly across the cell membrane [43].
One of the important mechanisms by which iron medi- urinary space as the glomerular permeability is markedly
increased. Transferrin is reabsorbed into the tubularates tissue injury is the generation of the hydroxyl radical
via the iron catalyzed Haber-Weiss reaction [44]. We cells, and the iron released from transferrin may lead to
the induction HO-1 and ferritin in the tubules [53].have recently shown that the heme moiety of CYP may
serve as a significant source of iron capable of catalyzing In conclusion, CYP2B1 was identified and localized
for the first time in the rat glomeruli but not the tubules.free radical reactions [11]. CYP is a hemeprotein com-
plex that undergoes suicidal inactivation under the action We demonstrated CYP2B1 as a site for the generation
of H2O2 and a significant source of catalytic iron partici-of active oxygen species with oxidative modification of
certain amino acids and bleaching of hemeproteins as a pating in the free radical reactions in this model of glo-
merular disease. The interaction between PAN andresult of heme loss or degradation [40]. Gutteridge has
demonstrated that the H2O2 and organic hydroperoxides CYP2B1 results in the generation of H2O2, which causes
inactivation of the heme protein with the release of hemecan oxidatively degrade hemoglobin and promote the
release of this iron from the heme chelate that catalyzes and iron. The free iron participates in the generation of
the hydroxyl radical. It also stimulates the synthesis ofthe generation of hydroxyl radical and stimulates lipid
peroxidation [6]. The bleomycin-detectable iron content ferritin, a scavenger of circulating free iron, thus pre-
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administration of cimetidine. J Pharmacol Exp Ther 260:1450–venting further injury. The released heme leads to the
1455, 1992
induction of HO-1, which is considered to be protective 17. Rendic S, Kajfez F, Ruf HH: Characterization of cimetidine,
ranitidine, and related structures’ interaction with cytochrome[12]. Our results could stimulate the identification and
P-450. Drug Metab Dispos 11:137–142, 1983localization of specific CYP isozymes in the human kid-
18. Baird MB, Sfeir GT, Slade-Pacini CD: Lack of inhibition of
ney and the development of specific inhibitors that could mouse catalase activity by cimetidine: An argument against a rele-
vant general effect of cimetidine upon heme metabolic pathways.prevent or ameliorate such injury.
Biochem Pharmacol 36:4366–4369, 1987
19. Baliga R, Baliga M, Shah SV: Effect of selenium-deficient diet
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